
浏览全部资源
扫码关注微信
1.广州中医院大学附属第二临床医学院泌尿外科,广州 510000
2.广东药科大学中药学院,广州 510000
陈桃芬,Email:1007380072@qq.com, 研究方向:中西医结合防治泌尿系肿瘤。
古炽明,Email:guchiming@gzucm.edu.cn。
收稿:2023-05-31,
修回:2023-06-30,
录用:2023-07-07,
纸质出版:2023-08-28
移动端阅览
陈桃芬,林雯丽,范华娜,等.血清转化生长因子、碱性磷酸酶、前列腺特异性抗原与转移性去势抵抗型前列腺癌的相关性分析[J].重庆医科大学学报,2023,48(8):916-920.
Chen Taofen,Lin Wenli,Fan Huana,et al.Correlations of serum transforming growth factor,alkaline phosphatase,and prostate-specific antigen with metastatic castration-resistant prostate cancer[J].Journal of Chongqing Medical University,2023,48(8):916-920.
陈桃芬,林雯丽,范华娜,等.血清转化生长因子、碱性磷酸酶、前列腺特异性抗原与转移性去势抵抗型前列腺癌的相关性分析[J].重庆医科大学学报,2023,48(8):916-920. DOI: 10.13406/j.cnki.cyxb.003303.
Chen Taofen,Lin Wenli,Fan Huana,et al.Correlations of serum transforming growth factor,alkaline phosphatase,and prostate-specific antigen with metastatic castration-resistant prostate cancer[J].Journal of Chongqing Medical University,2023,48(8):916-920. DOI: 10.13406/j.cnki.cyxb.003303.
目的
2
探讨前列腺癌骨转移患者血清中转化生长因子-β1(transforming growth factor-β1,TGF-β1)、碱性磷酸酶(alkaline phosphatase,ALP)、前列腺特异抗原(prostate specific antigen,PSA)与患者发生转移性去势抵抗性前列腺癌(metastatic castration-resistant prostate cancer,mCRPC)的相关性。
方法
2
根据回顾性研究的方法,选择2022年1月至2023年2月广东省中医院确诊为前列腺癌骨转移的患者为研究对象,根据是否发生CRPC分为2组,CRPC组26例,非CRPC组29例。收集患者一般资料,并通过酶联免疫吸附实验测定患者血清TGF-β1、ALP、PSA的水平进行分析。
结果
2
在2组单因素比较中,血清PSA的差异没有统计学意义(
Ρ
>
0.05),血清TGF-β1、ALP的差异具有统计学意义(
Ρ
<
0.05)。二元logistic回归分析显示,TGF-β1是CRPC发生的独立危险因素。Spearman相关性分析显示,在CRPC患者血清中TGF-β1和ALP水平呈正相关。
结论
2
TGF-β1及ALP水平与前列腺癌骨转移患者疾病侵袭和进展密切相关,可能为前列腺癌骨转移患者治疗及预后提供评估依据。
Objective
2
To investigate the correlations of serum transforming growth factor(TGF)-β1,prostate-specific antigen(PSA),and alkaline phosphatase(ALP) with the occurrence of metastatic castration-resistant prostate cancer(mCRPC) in patients with prostate cancer bone metastases.
Methods
2
Using the method of retrospective study,patients diagnosed with bone metastasis of prostate cancer in Guangdong Provincial Hospital of Chinese Medicine from January 2022 to February 2023 were selected and divided into CRPC group(26 cases) and non-CRPC group(29 cases). The general information of patients was collected,and the levels of serum TGF-β1,ALP,and PSA were measured using enzyme-linked immunosorbent assay.
Results
2
Univariate analysis was performed between the two groups. The difference in serum PSA was not significant(
P
>
0.05),while the differences in serum TGF-β1 and ALP were statistically significant(
P
<
0.05). Binary logistic regression analysis showed that TGF-β1 was an independent risk factor for the occurrence of mCRPC. Spearman correlation analysis showed a positive c
orrelation between serum TGF-β1 and ALP in patients with mCRPC.
Conclusion
2
TGF-β1 and ALP levels are closely related to the invasion and progression of prostate cancer bone metastases. Our results may provide a basis for evaluating the treatment and prognosis of patients with prostate cancer bone metastases.
Sung H , Ferlay J , Siegel R L , et al . Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA : A Cancer Journal for Clinicians , 2021 , 71 ( 3 ): 209 - 249 .
Prostate cancer treatment-China’s perspective [J ] . Cancer Letters ,Elsevier, 2022 , 550 : 215927 .
Siegel RL , Miller KD , Jemal A . Cancer statistics,2019 [J ] . CA:A Cancer Journal for Clinicians , 2019 , 69 ( 1 ): 7 - 34 .
Akaza H , Procopio G , Pripatnanont C , et al . Metastatic castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy:treatment patterns from the PROXIMA prospective registry [J ] . Journal of Global Oncology , 2018 , 4 : 1 - 12 .
Wang G , Zhao D , Spring DJ , et al . Genetics and biology of prostate cancer [J ] . Genes & Development , 2018 , 32 ( 17/18 ): 1105 - 1140 .
Esposito M , Fang C , Cook KC , et al . TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis [J ] . Nature Cell Biology , 2021 , 23 ( 3 ): 257 - 267 .
Ahel J , Hudorović N , Vičić-Hudorović V , et al . TGF-Beta in the Natural History of Prostate Cancer [J ] . Acta clinica Croatica ,Klinički bolnički centar Sestre milosrdnice, 2019 , 58 ( 1 ): 128 - 138 .
Bellomo C , Caja L , Moustakas A . Transforming growth factor β as regulator of cancer stemness and metastasis [J ] . British Journal of Cancer , 2016 , 115 ( 7 ): 761 - 769 .
Cabioglu N , Gong Y , Islam R , et al . Expression of growth factor and chemokine receptors:new insights in the biology of inflammatory breast cancer [J ] . Annals of Oncology , 2007 , 18 ( 6 ): 1021 - 1029 .
Singh OP , Yogi V , Redhu P , et al . Role of serum prostate-specific antigen as predictor for bone metastases in newly diagnosed prostate cancer [J ] . Journal of Cancer Research and Therapeutics , 2019 , 15 ( Suppl ): S39 - S41 .
钱友良 , 陈智彬 , 黄朝友 , 等 . 前列腺特异性抗原动态分析对阿比特龙治疗的去势抵抗性前列腺癌患者预后的预测价值 [J ] . 中国临床药理学杂志 , 2020 , 36 ( 18 ): 2778 – 2781 .
Qian YL , Chen ZB , Huang CY , et al . Predictive value of prostate- specific antigen variables on prognosis in castration-resistant prostate cancer patients treated with abiraterone [J ] . Chin J Clinical Pharmacology , 2020 , 36 ( 18 ): 2778 - 2781 .
黄凤鸣 , 李晓红 , 梁 勇 . 伴骨转移前列腺癌患者内分泌治疗后出现早期CRPC的危险因素分析 [J ] . 中华男科学杂志 , 2018 , 24 ( 8 ): 690 – 694 .
Huang FM , Li XH , Liang Y . Risk factors for early castration-resistant prostate cancer after androgen deprivation therapy for bone-metastatic prostate cancer [J ] . Chin J Andrology , 2018 , 24 ( 8 ): 690 - 694 .
Dranoff G . Cytokines in cancer pathogenesis and cancer therapy [J ] . Nature Reviews Cancer , 2004 , 4 ( 1 ): 11 - 22 .
Wang W , Yang X , Dai J , et al . Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion [J ] . Oncogene , 2019 , 38 ( 23 ): 4540 - 4559 .
吕玉宇 , 邓 玮 , 杨明清 , 等 . 前列腺癌组织和细胞中LKB1、TGF-β1的表达及意义 [J ] . 重庆医科大学学报 , 2016 , 41 ( 7 ): 761 - 766 .
Lü YY , Deng W , Yang MQ , et al . Significance of LKB1 and TGF-β1 expression in human prostate cancer tissues and cell lines [J ] . Journal of Chongqing Medical University , 2016 , 41 ( 7 ): 761 - 766 .
汤锶锶 , 刘恒炼 , 白殊同 , 等 . 补肾活血方联合宫腔灌注治疗对宫腔粘连相关机制TGF-β1、Smad2和Smad3的影响分析 [J ] . 重庆医科大学学报 , 2020 , 45 ( 5 ): 660 - 666 .
Tang SS , Liu HL , Bai ST , et al . Effect of kidney-tonifying and blood-activating decoction combined with intrauterine perfusion on intrauterine adhesion mechanisms of TGF-β1,Smad2 and Smad3 [J ] . Journal of Chongqing Medical University , 2020 , 45 ( 5 ): 660 - 666 .
Geiser AG , Zeng QQ , Sato M , et al . Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene [J ] . Bone , 1998 , 23 ( 2 ): 87 - 93 .
Balooch G , Balooch M , Nalla RK , et al . TGF-beta regulates the mechanical properties and composition of bone matrix [J ] . Proceedings of the National Academy of Sciences of the United States of America , 2005 , 102 ( 52 ): 18813 - 18818 .
Taichman RS , Loberg RD , Mehra R , et al . The evolving biology and treatment of prostate cancer [J ] . Journal of Clinical Investigation , 2007 , 117 ( 9 ): 2351 - 2361 .
Dai Y , Wu Z , Lang C , et al . Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling [J ] . Theranostics , 2019 , 9 ( 21 ): 6063 - 6079 .
Dai Y , Ren D , Yang Q , et al . The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone [J ] . British Journal of Cancer , 2017 , 117 ( 5 ): 685 - 694 .
Esposito M , Fang C , Cook KC , et al . TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis [J ] . Nature Cell Biology , 2021 , 23 ( 3 ): 257 - 267 .
Juárez P , Guise TA . TGF-β in cancer and bone:Implications for treatment of bone metastases [J ] . Bone , 2011 , 48 ( 1 ): 23 - 29 .
Quinn JM , Itoh K , Udagawa N , et al . Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions [J ] . Journal of Bone and Mineral Research:The Official Journal of the American Society for Bone and Mineral Research , 2001 , 16 ( 10 ): 1787 - 1794 .
Ma H , Liu T , Xu Y , et al . MiR-519d and miR-328-3p Combinatorially Suppress Breast Cancer Progression [J ] . Onco Targets and Therapy , 2020 , 13 : 12987 - 12997 .
Fridlender ZG , Sun J , Kim S , et al . Polarization of Tumor-Associated Neutrophil(TAN) Phenotype by TGF-β:“N1” versus “N2” TAN [J ] . Cancer cell , 2009 , 16 ( 3 ): 183 - 194 .
Costanzo-Garvey DL , Keeley T , Case AJ , et al . Neutrophils are mediators of metastatic prostate cancer progression in bone [J ] . Cancer Immunology ,Immunotherapy:CII, 2020 , 69 ( 6 ): 1113 - 1130 .
Lebrun JJ . The dual role of TGF-β in human cancer:from tumor suppression to cancer metastasis [J ] . ISRN Molecular Biology , 2012 , 2012 : 381428 .
Tsubakihara Y , Moustakas A . Epithelial-mesenchymal transition and metastasis under the control of transforming growth factor β [J ] . International Journal of Molecular Sciences , 2018 , 19 ( 11 ): 3672 .
张炜浩 . TGF-β1、VEGF在前列腺癌临床分期及冷冻治疗前后表达的临床意义 [D ] . 天津 : 天津医科大学 , 2014 .
Zhang WH . The value of TGF-β1,VEGF expression for clinical stage and cryoablation in prostate cancer [D ] . Tianjin : Tianjin Medical University , 2014 .
孙斌 , 刘举珍 , 蔡铁铁 , 等 . 血清TGF-β1、VEGF及IL-6水平与前列腺癌骨转移相关性分析 [J ] . 临床和实验医学杂志 , 2018 , 17 ( 19 ): 2086 - 2089 .
Sun B , Liu JZ , Cai TT , et al . Correlation of serum TGF-β1,VEGF and IL-6 with bone metastasis of prostate cancer [J ] . Journal of Clinical and Experimental Medicine , 2018 , 17 ( 19 ): 2086 - 2089 .
0
浏览量
5
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621